These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 30283456

  • 1. Active Tuberculosis Is Characterized by Highly Differentiated Effector Memory Th1 Cells.
    Arrigucci R, Lakehal K, Vir P, Handler D, Davidow AL, Herrera R, Estrada-Guzmán JD, Bushkin Y, Tyagi S, Lardizabal AA, Gennaro ML.
    Front Immunol; 2018; 9():2127. PubMed ID: 30283456
    [Abstract] [Full Text] [Related]

  • 2. Study of CD27 and CCR4 Markers on Specific CD4+ T-Cells as Immune Tools for Active and Latent Tuberculosis Management.
    Latorre I, Fernández-Sanmartín MA, Muriel-Moreno B, Villar-Hernández R, Vila S, Souza-Galvão ML, Stojanovic Z, Jiménez-Fuentes MÁ, Centeno C, Ruiz-Manzano J, Millet JP, Molina-Pinargote I, González-Díaz YD, Lacoma A, Luque-Chacón L, Sabriá J, Prat C, Domínguez J.
    Front Immunol; 2018; 9():3094. PubMed ID: 30687314
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.
    Adekambi T, Ibegbu CC, Kalokhe AS, Yu T, Ray SM, Rengarajan J.
    PLoS One; 2012; 7(4):e36046. PubMed ID: 22545156
    [Abstract] [Full Text] [Related]

  • 6. Circulating mycobacterial-reactive CD4+ T cells with an immunosuppressive phenotype are higher in active tuberculosis than latent tuberculosis infection.
    Kim K, Perera R, Tan DB, Fernandez S, Seddiki N, Waring J, French MA.
    Tuberculosis (Edinb); 2014 Sep; 94(5):494-501. PubMed ID: 25095750
    [Abstract] [Full Text] [Related]

  • 7. CD137 is a Useful Marker for Identifying CD4+ T Cell Responses to Mycobacterium tuberculosis.
    Yan ZH, Zheng XF, Yi L, Wang J, Wang XJ, Wei PJ, Jia HY, Zhou LJ, Zhao YL, Zhang HT.
    Scand J Immunol; 2017 May; 85(5):372-380. PubMed ID: 28218958
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Activation Phenotype of Mycobacterium tuberculosis-Specific CD4+ T Cells Promoting the Discrimination Between Active Tuberculosis and Latent Tuberculosis Infection.
    Luo Y, Xue Y, Mao L, Lin Q, Tang G, Song H, Liu W, Tong S, Hou H, Huang M, Ouyang R, Wang F, Sun Z.
    Front Immunol; 2021 May; 12():721013. PubMed ID: 34512645
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of CD4/CD8+ αβ and Vγ2Vδ2+ T cells in HIV-negative individuals with different Mycobacterium tuberculosis infection statuses.
    Gao Y, Zhang S, Ou Q, Shen L, Wang S, Wu J, Weng X, Chen ZW, Zhang W, Shao L.
    Hum Immunol; 2015 Nov; 76(11):801-7. PubMed ID: 26429305
    [Abstract] [Full Text] [Related]

  • 12. CD4 T Cells in Mycobacterium tuberculosis and Schistosoma mansoni Co-infected Individuals Maintain Functional TH1 Responses.
    McLaughlin TA, Khayumbi J, Ongalo J, Tonui J, Campbell A, Allana S, Gurrion Ouma S, Odhiambo FH, Gandhi NR, Day CL.
    Front Immunol; 2020 Nov; 11():127. PubMed ID: 32117277
    [Abstract] [Full Text] [Related]

  • 13. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus.
    Petruccioli E, Chiacchio T, Pepponi I, Vanini V, Urso R, Cuzzi G, Barcellini L, Cirillo DM, Palmieri F, Ippolito G, Goletti D.
    J Infect; 2016 Dec; 73(6):588-597. PubMed ID: 27717779
    [Abstract] [Full Text] [Related]

  • 14. Combination of HLA-DR on Mycobacterium tuberculosis-Specific Cells and Tuberculosis Antigen/Phytohemagglutinin Ratio for Discriminating Active Tuberculosis From Latent Tuberculosis Infection.
    Luo Y, Xue Y, Tang G, Lin Q, Song H, Liu W, Yin B, Huang J, Wei W, Mao L, Wang F, Sun Z.
    Front Immunol; 2021 Dec; 12():761209. PubMed ID: 34858413
    [Abstract] [Full Text] [Related]

  • 15. Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis.
    Petruccioli E, Petrone L, Vanini V, Cuzzi G, Navarra A, Gualano G, Palmieri F, Girardi E, Goletti D.
    J Infect; 2015 Nov; 71(5):526-33. PubMed ID: 26253021
    [Abstract] [Full Text] [Related]

  • 16. Functional, Antigen-Specific Stem Cell Memory (TSCM) CD4+ T Cells Are Induced by Human Mycobacterium tuberculosis Infection.
    Mpande CAM, Dintwe OB, Musvosvi M, Mabwe S, Bilek N, Hatherill M, Nemes E, Scriba TJ, SATVI Clinical Immunology Team.
    Front Immunol; 2018 Nov; 9():324. PubMed ID: 29545791
    [Abstract] [Full Text] [Related]

  • 17. PD-1 Expression on Mycobacterium tuberculosis-Specific CD4 T Cells Is Associated With Bacterial Load in Human Tuberculosis.
    Day CL, Abrahams DA, Bunjun R, Stone L, de Kock M, Walzl G, Wilkinson RJ, Burgers WA, Hanekom WA.
    Front Immunol; 2018 Nov; 9():1995. PubMed ID: 30233588
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic performance of a cytokine and IFN-γ-induced chemokine mRNA assay after Mycobacterium tuberculosis-specific antigen stimulation in whole blood from infected individuals.
    Kim S, Lee H, Kim H, Kim Y, Cho JE, Jin H, Kim DY, Ha SJ, Kang YA, Cho SN, Lee H.
    J Mol Diagn; 2015 Jan; 17(1):90-9. PubMed ID: 25528189
    [Abstract] [Full Text] [Related]

  • 19. Mycobacteria-Specific Mono- and Polyfunctional CD4+ T Cell Profiles in Children With Latent and Active Tuberculosis: A Prospective Proof-of-Concept Study.
    Tebruegge M, Ritz N, Donath S, Dutta B, Forbes B, Clifford V, Zufferey C, De Rose R, Robins-Browne RM, Hanekom W, Graham SM, Connell T, Curtis N.
    Front Immunol; 2019 Jan; 10():431. PubMed ID: 31024518
    [Abstract] [Full Text] [Related]

  • 20. Th1, Th17, and Th1Th17 Lymphocytes during Tuberculosis: Th1 Lymphocytes Predominate and Appear as Low-Differentiated CXCR3+CCR6+ Cells in the Blood and Highly Differentiated CXCR3+/-CCR6- Cells in the Lungs.
    Nikitina IY, Panteleev AV, Kosmiadi GA, Serdyuk YV, Nenasheva TA, Nikolaev AA, Gorelova LA, Radaeva TV, Kiseleva YY, Bozhenko VK, Lyadova IV.
    J Immunol; 2018 Mar 15; 200(6):2090-2103. PubMed ID: 29440351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.